Plasma cytokine profiles in Preprotachykinin-A knockout mice subjected to polymicrobial sepsis

Molecular Medicine

Volumn 16, Issue 1-2, 2010, Pages 45-52

  Hegde, Akhil ^a   Uttamchandani, Mahesh ^b   Moochhala, Shabbir M ^a,b   Bhatia, Madhav ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DSO NATIONAL LABORATORIES   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; PREPROTACHYKININ A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNE SYSTEM; LIGATION; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SEPSIS; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; CECUM; CYTOKINES; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PROTEIN PRECURSORS; SEPSIS; TACHYKININS;

EID: 73949090976     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00112     Document Type: Article

References (50)

1. Matsuda M, Hattori Y. (2006) Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. J. Pharmacol. Sci. 101:189-98.
2. Cavaillon JM, Annane D. (2006) Compartmentalization of the inflammatory response in sepsis and SIRS. J. Endotoxin Res. 12:151-70.
3. Ray CA, et al. (2005) Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. J. Pharm. Biomed. Anal. 36:1037-44.
4. de Jager W, Rijkers GT. (2006) Solid-phase and bead-based cytokine immunoassay: a comparison. Methods. 38:294-303.
5. Ashare A, et al. (2005) Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am. J. Physiol. Lung Cell Mol. Physiol. 288:L633-40.
6. Reddy RC, Chen GH, Tekchandani PK, Standiford TJ. (2001) Sepsis-induced immunosuppression: from bad to worse. Immunol. Res. 24:273-87.
7. van der Poll T, Deventer SJ. (1999) Cytokines and anticytokines in the pathogenesis of sepsis. Infect. Dis. Clin. North Am. 13:413-26.
8. Okazaki Y, Matsukawa A. (2009) Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis. Recent Pat. Inflamm. Allergy Drug Discov. 3:26-32.
9. Marshall JC, et al. (2003). Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit. Care Med. 31:1560-7.
10. Ramnath RD, et al. (2006) Inflammatory mediators in sepsis: Cytokines, chemokines, adhesion molecules and gases. J. Organ Dysfunction. 2:80-92.
11. Ng SW, Zhang H, Hegde A, Bhatia M. (2008) Role of preprotachykinin-A gene products on multiple organ injury in LPS-induced endotoxemia. J. Leukoc. Biol. 83:288-95.
12. Puneet P, et al. (2006) Preprotachykinin-A gene products are key mediators of lung injury in polymicrobial sepsis. J. Immunol. 176:3813-20.
13. Zhang H, et al. (2007) Hydrogen sulfide upregulates substance P in polymicrobial sepsis-associated lung injury. J. Immunol. 179:4153-60.
14. Osuchowski MF, Welch K, Siddiqui J, Remick DG. (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177:1967-74.
15. Kingsmore SF. (2006) Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5:310-20.
16. Nolan JP, Mandy F. (2006) Multiplexed and microparticle-based analyses: quantitative tools for the large-scale analysis of biological systems. Cytometry A. 69:318-25.
17. Vignali DA. (2000) Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 243:243-55.
18. Dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL. (2005) Validation and comparison of Luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J. Reprod. Immunol. 66:175-91.
19. Prabhakar U, Eirikis E, Davis HM. (2002) Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J. Immunol. Methods. 260:207-18.
20. Linkov F, et al. (2007) Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling. Cancer Epidemiol. Biomarkers Prev. 16:102-7.
21. Ayala A, Herdon CD, Lehman DL, Ayala CA, Chaudry IH. (1996) Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood. 87:4261-75.
22. Zhou M, Chaudry IH, Wang P. (2001) The small intestine is an important source of adrenomedullin release during polymicrobial sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R654-60.
23. Baker CC, Chaudry IH, Gaines HO, Baue AE. (1983) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 94:331-5.
24. Zhang H, Zhi L, Moochhala S, Moore PK, Bhatia M. (2007) Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappaB. Am. J. Physiol. Lung Cell Mol. Physiol. 292:L960-71.
25. Ertel W, et al. (1991) The complex pattern of cytokines in sepsis: Association between prostaglandins, cachectin, and interleukins. Ann. Surg. 214:141-8.
26. Salkowski CA, Detore G, Franks A, Falk MC, Vogel SN. (1998) Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid a prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect. Immun. 66:3569-78.
27. Liu MY, et al. (2005) Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 System. Clin. Chem. 51:1102-9.
28. Cooper AM, Khader SA. (2007) IL-12p40: an inherently agonistic cytokine. Trends Immunol. 28:33-38.
29. Ho WZ, Lai JP, Zhu XH, Uvaydova M, Douglas SD. (1997) Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol. 159:5654-60.
30. Lai JP, Douglas SD, Ho WZ. (1998) Human lymphocytes express substance P and its receptor. J. Neuroimmunol. 86:80-6.
31. O'Connor TM, et al. (2004) The role of substance P in inflammatory disease. J. Cell Physiol. 201:167-80.
32. Cao YQ, et al. (1998) Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 392:390-4.
33. Rizzo CA, Valentine AF, Egan RW, Kreutner W, Hey JA. (1999) NK(2)-receptor mediated contraction in monkey, guinea-pig and human airway smooth muscle. Neuropeptides. 33:27-34.
34. Groneberg DA, Quarcoo D, Frossard N, Fischer A. (2004) Neurogenic mechanisms in bronchial inflammatory diseases. Allergy. 59:1139-52.
35. Blackwell TS, Christman JW. (1996) Sepsis and cytokines: current status. Br. J. Anaesth. 77:110-7.
36. Sriskandan S, Altmann DM. (2008). The immunology of sepsis. J. Pathol. 214:211-23.
37. Ness TL, et al. (2004) CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis. J. Immunol. 173:6938-48.
38. Ness TL, Hogaboam CM, Strieter RM, Kunkel SL. (2003) Immunomodulatory role of CXCR2 during experimental septic peritonitis. J. Immunol. 171:3775-84.
39. Takahashi H, et al. (2002) An essential role of macrophage inflammatory protein 1alpha/CCL3 on the expression of host's innate immunities against infectious complications. J. Leukocyte Biol. 72:1190-7.
40. Matsukawa A, et al. (2000) Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response. J. Immunol. 164:5362-8.
41. Zhu S, et al. (2009) Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol. Med. 15:275-82.
42. Torres MB, et al. (2005) IL-10 plasma levels are elevated after LPS injection in splenectomized A/J mice. J. Surg. Res. 129:101-6.
43. Hotchkiss RS, Karl IE. (2003). The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138-50.
44. Song GY, Chung CS, Chaudry IH, Ayala A. (1999) What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? Surgery. 126:378-83.
45. Latifi SQ, O'Riordan MA, Levine AD. (2002) Interleukin-10 controls the onset of irreversible septic shock. Infect. Immun. 70:4441-6.
46. Trinchieri G, Pflanz S, Kastelein RA. (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 19:641-4.
47. Wysocka M, et al. (1995) Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672-6.
48. Kuhns DB, Alvord WG, Gallin JI. (1995) Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J. Infect. Dis. 171:145-52.
49. Gårdlund B, et al. (1995) Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J. Infect. Dis. 172:296-301.
50. Cinel I, Opal SM. (2009) Molecular biology of inflammation and sepsis: A primer. Crit. Care Med. 37:291-304.